Why HIV Mutates So Rapidly: Reverse Transcriptase Errors and Clinical Consequences
HIV's extraordinary mutation rate stems from its replication enzyme, reverse transcriptase (RT), which converts viral RNA into DNA. Unlike cellular DNA polymerases, RT lacks a proofreading (3'→5' exonuclease) function, so errors (misincorporations, insertions, deletions) go uncorrected.
Consequences of High Mutation Rate
- Immune evasion: Rapidly changing envelope glycoproteins (gp120/gp41) outpace antibody and CTL responses.
- Tissue tropism adaptation: Mutations allow infection of diverse cell types (CD4+ T cells, macrophages, microglia, dendritic cells).
- Drug resistance: Single-point mutations confer resistance to NRTIs, NNRTIs, PIs, INSTIs. Resistance emerges quickly with monotherapy or poor adherence.
- Vaccine challenge: Global sequence diversity complicates immunogen design.
Clinical Implications
- Combination antiretroviral therapy (cART) with ≥3 drugs from ≥2 classes suppresses replication below resistance threshold.
- Resistance testing (genotypic/phenotypic) guides regimen selection.
- Novel strategies: broadly neutralizing antibodies, capsid inhibitors, latency-reversing agents aim to stay ahead of viral evolution.
HIV's mutability is a formidable obstacle, but also drives innovation in antiviral development.
HIV & AIDS - Related Articles
- Candidiasis & HIV: Symptoms, Treatment & Prevention
- PrEP for HIV Prevention: Mechanism, Effectiveness & Clinical Guidance
- Syphilis Transmission: Routes, Congenital Risk, and Myths
- Understanding AIDS: Symptoms, Stages & HIV Connection
- HIV/AIDS: Comprehensive Guide to Transmission, Stages, Treatment, and Prevention
- Understanding the Societal Impact of HIV/AIDS in India
- Understanding the Progress of HIV/AIDS Treatment
